Literature DB >> 9308012

Cyclin-dependent protein kinase 5 activity increases in rat brain following ischemia.

S L Green1, K S Kulp, R Vulliet.   

Abstract

Cyclin-dependent kinase 5 (CDK5) is the 34 kDa catalytic subunit of a recently characterized neuronal cdc2-like protein kinase which appears to be involved in regulation of the neurocytoskeleton. Using the rat postdecapitative model, the effect of brain ischemia on histone H1 and tau protein CDK5 phosphorylating activity was examined. Histone H1 kinase activity increased in both cytosolic and particulate fractions of the hippocampus and neocortex after 5 min and 15 min of ischemia, then declined to control levels. CDK5 tau protein phosphorylating activity increased after 15 min ischemia; however, no electrophoretic shifts or changes in radiodensity of the tau bands were observed autoradiographically. On Western blot analysis, the CDK5 protein band did not change after 25 min ischemia, despite the increase and subsequent decline in enzyme activity. These data demonstrate a postischemic increase in CDK5 activity, an associated increase in CDK5 tau phosphorylating activity and a decline in activity in the absence of massive proteolysis. CDK5 appears to play a role in the events associated with neuronal response to ischemic injury.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9308012     DOI: 10.1016/s0197-0186(97)00012-0

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  9 in total

1.  Overexpression of Cdk5 or non-phosphorylatable retinoblastoma protein protects septal neurons from oxygen-glucose deprivation.

Authors:  Kiran S Panickar; Doris Nonner; Michael G White; John N Barrett
Journal:  Neurochem Res       Date:  2008-03-20       Impact factor: 3.996

2.  Negative regulation of cyclin-dependent kinase 5 targets by protein kinase C.

Authors:  Bogachan Sahin; Ammar H Hawasli; Robert W Greene; Jeffery D Molkentin; James A Bibb
Journal:  Eur J Pharmacol       Date:  2008-01-10       Impact factor: 4.432

3.  Activation of AKT1/GSK-3β/β-Catenin-TRIM11/Survivin Pathway by Novel GSK-3β Inhibitor Promotes Neuron Cell Survival: Study in Differentiated SH-SY5Y Cells in OGD Model.

Authors:  B S Darshit; M Ramanathan
Journal:  Mol Neurobiol       Date:  2015-12-11       Impact factor: 5.590

Review 4.  An unusual member of the Cdk family: Cdk5.

Authors:  Fatema A Dhariwala; Medha S Rajadhyaksha
Journal:  Cell Mol Neurobiol       Date:  2008-01-08       Impact factor: 5.046

5.  Cyclin-dependent kinase five mediates activation of lung xanthine oxidoreductase in response to hypoxia.

Authors:  Bo S Kim; Leonid Serebreni; Jonathan Fallica; Omar Hamdan; Lan Wang; Laura Johnston; Todd Kolb; Mahendra Damarla; Rachel Damico; Paul M Hassoun
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

6.  Zinc induces CDK5 activation and neuronal death through CDK5-Tyr15 phosphorylation in ischemic stroke.

Authors:  Qing-Zhang Tuo; Zhen-Yu Liuyang; Peng Lei; Xiong Yan; Yang-Ping Shentu; Jia-Wei Liang; Huan Zhou; Lei Pei; Yan Xiong; Tong-Yao Hou; Xin-Wen Zhou; Qun Wang; Jian-Zhi Wang; Xiao-Chuan Wang; Rong Liu
Journal:  Cell Death Dis       Date:  2018-08-29       Impact factor: 8.469

7.  The Peptide-Directed Lysosomal Degradation of CDK5 Exerts Therapeutic Effects against Stroke.

Authors:  Ya-Fan Zhou; Jing Wang; Man-Fei Deng; Bin Chi; Na Wei; Jian-Guo Chen; Dan Liu; Xiaoping Yin; Youming Lu; Ling-Qiang Zhu
Journal:  Aging Dis       Date:  2019-10-01       Impact factor: 6.745

Review 8.  Cellular and Molecular Mechanisms of R/S-Roscovitine and CDKs Related Inhibition under Both Focal and Global Cerebral Ischemia: A Focus on Neurovascular Unit and Immune Cells.

Authors:  Lucas Le Roy; Anne Letondor; Cloé Le Roux; Ahmed Amara; Serge Timsit
Journal:  Cells       Date:  2021-01-08       Impact factor: 6.600

Review 9.  Protection after stroke: cellular effectors of neurovascular unit integrity.

Authors:  Rafael Andres Posada-Duque; George E Barreto; Gloria Patricia Cardona-Gomez
Journal:  Front Cell Neurosci       Date:  2014-08-14       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.